| Bayer Partners with Atara Therapeutics for Mesothelin-directed CAR-T Therapies |
Abstract
pdf
html
|
|
Shikha Kashyap & Michelle Liu |
|
| Novartis Licenses Anti-PD1 Antibody Tislelizumab from BeiGene in US$2.2 B Deal |
Abstract
pdf
html
|
|
Neha Madhwani & Michelle Liu |
|
| Coherus Catapults into Immuno-oncology Field with US$1.8 B Junshi Alliance |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Merck Ventures Further into Natural Killer Therapies with US$1.9 B Artiva Alliance |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Horizon Continues to Build Rare Disease Pipeline with US$3.05 B Viela Buy |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Boehringer Ingelheim Buys ADC Specialist NBE-Therapeutics for US$1.43 B |
Abstract
pdf
html
|
|
Ashish Tripathi & Michelle Liu |
|
